Small Cap Gainers: KROS, SD, RRD
3:26 pm Monday, September 27th, 2021
Keros Therapeutics, Inc. (NASDAQ:KROS) Surges to its highest levels since mid-July on above 9x average volume. Various biotech names, including several with programs for pulmonary arterial hypertension, spike in sympathy with Acceleron Pharma (XLRN) upon reports indicating that it is fielding takeover interest.
SandRidge Energy, Inc. (NSE:SD) Trades up to new three-year highs in a generally strong session for the energy sector, supported by higher oil prices. SandRidge Energy, Inc. engages in the acquisition, development, and production of oil and natural gas primarily in the United States Mid-Continent. As of December 31, 2020, it holds interest in approximately 380,000 net leasehold acres in Oklahoma and Kansas, as well as total proved developed reserves of 33.4 million barrels of oil equivalent. The company was incorporated in 2006 and is headquartered in Oklahoma City, Oklahoma.
RR Donnelley & Sons Co (NYSE:RRD) Received a letter from Chatham Asset Management, which manages funds that own approx. 14.9% of co’s outstanding common stock, calling for initiatives that it believes must be implemented to stabilize co’s share price and drive future value creation, including the formation of a “clear strategic review process focused on the identification and sale of non-core assets”, among other measures. In other recent press, co announced that it is today highlighting its end-to-end, single-source capabilities for premium folding carton production while at PACK EXPO Las Vegas.
